Sanofi-Aventis, Effortil 15ml Sanofi-Aventis

The medicine is a means of increasing blood pressure.
The drug is used for circulatory disorders with low blood pressure (hypotension), which are accompanied by symptoms such as dizziness, a feeling of weakness, pallor, sweating, flickering or darkening before the eyes, as well as a significant drop in blood pressure without an increase in heart rate when changing body position (for example, when getting up from a lying or sitting position).
Active ingredients
7.5 mg etilephrine hydrochloride
Excipients
purified water, sodium disulfite, methyl 4-hydroxybenzoate, propyl 4-hydroxybenzoate.
Dosage:
Unless otherwise prescribed by a doctor, the recommended dose is:
For adults and children over 6 years old:
10-20 drops 3 times a day. This corresponds to a daily dose of 15-30 mg etilephrine hydrochloride.
For children aged 2 to 6 years:
5-10 drops 3 times a day. This corresponds to a daily dose of 7.5-15 mg etilephrine hydrochloride.
For children under 2 years:
2-5 drops 3 times a day. This corresponds to a daily dose of 3-7.5 mg etilephrine hydrochloride.
It is advisable to take the drug before meals with a glass of liquid.
It is recommended for children to give it in a teaspoon of juice or sweetened tea.
The drug should not be taken in the afternoon or evening, as its stimulating effect may make it difficult to fall asleep.
The need for taking the drug should be checked regularly.
Side effects
immune system disorders – hypersensitivity (allergic reaction)
mental disorders
uncommon: anxiety
nervous system disorders
common: headache
uncommon: anxiety, insomnia, muscle tremors (tremors), dizziness
heart disease
uncommon: increased heart rate, tachycardia, cardiac arrhythmias with extra contractions (ventricular arrhythmias)
frequency unknown: feeling of pressure over the heart (angina complaints), increased blood pressure (possibly with headache)
gastrointestinal tract
common: gastrointestinal complaints
occasional nausea
general diseases
frequency unknown: increased sweating.
The drug should not be taken in the first 3 months of pregnancy.
The drug can be taken from the 4th month of pregnancy, if the attending physician approves it.
The drug should not be taken during breastfeeding.